Microbot Medical (MBOT) Receives a Buy from Roth MKM

Tip Ranks
2025.12.03 05:36
portai
I'm PortAI, I can summarize articles.

Roth MKM analyst Kyle Bauser has given Microbot Medical (MBOT) a Buy rating with a $5.50 price target. Bauser, who covers the Healthcare sector, has an average return of -12.3% and a 37.93% success rate on recommended stocks. The analyst consensus on Microbot Medical is a Moderate Buy with an average price target of $8.75.

Microbot Medical received a Buy rating and a $5.50 price target from Roth MKM analyst Kyle Bauser today.

TipRanks Cyber Monday Sale

  • Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
  • Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

Bauser covers the Healthcare sector, focusing on stocks such as Sanuwave Health, HeartBeam, and Electromed. According to TipRanks, Bauser has an average return of -12.3% and a 37.93% success rate on recommended stocks.

Currently, the analyst consensus on Microbot Medical is a Moderate Buy with an average price target of $8.75.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer